P&S Market Research releases a new research report with market overview, trends, DRO analysis, market segmentation, market size, share, forecast, porter analysis, recent developments, competitive scenario and top competitor profiles in:
Global Industry Insight: Human Insulin Market development and demand forecast to 2020
Browse Report Description and Table of Content:
The global human insulin market is expected to witness double digit growth during the period 2015 to 2020 to reach $48,487.7 million value by 2020. The global human insulin market is being driven by increasing prevalence of diabetic population, and rise in aging population. Diabetes is a chronic and non-communicable disease, and its global prevalence is increasing enormously. Rising prevalence of obesity, rising awareness about diabetic care, and technological advancement in insulin delivery devices are some of the factors driving the growth of the global human insulin market. Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market
Request for Report Sample:
Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020. In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin. Also, in Asia Pacific region, several government initiatives are implemented to create awareness about prevention and treatment of diabetes. The government is also taking initiatives to improve healthcare infrastructure and provide treatment in rural areas. In Asia-Pacific, the human insulin market is expected to witness CAGR of 13.9% during the period 2015 to 2020.
The global human insulin market has a fragmented structure with large number of companies operating in the market. The key players in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar.
Human Insulin Market Segmentation
Human Insulin Market by type
- Traditional human insulin
- Modern human insulin
Traditional Human Insulin Market by type
- Short acting human insulin
- Intermediate acting human insulin
- Premixed human insulin
Modern Human Insulin Market by type
- Long acting human insulin
- Rapid acting human insulin
- Premixed human insulin
Human Insulin Market by Brand
Human Insulin Market by Region
- North America
- The U.S.
- The U.K.
- Rest of the World (ROW)
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Company Name: P&S Market Research
Contact Person: Ms Somya
Phone: +1-888-778-7886 (USA/Canada)
Address:347, 5th Ave. #1402
City: New York City
Country: United States